Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
TwoStep Therapeutics raised $62.5 million in an oversubscribed Series A financing, securing funding for their first-in-class peptide-drug conjugate.
PRIVATESep 09, 2026•about 3 hours ago
Amount Raised
$62.5 Million
Round Type
Series A
Palo AltoBiotechnology
Description
TwoStep Therapeutics has announced the closing of its oversubscribed $62.5 million Series A financing. This funding follows the FDA clearance of the IND for their first-in-class peptide-drug conjugate. The capital will support the advancement of their innovative therapeutic pipeline.
Company Information
Company
TwoStep Therapeutics
Location
C/O COOLEY LLP, 3175 HANOVER STREET
Palo Alto, California, United States
About
TwoStep Therapeutics is a venture-backed early-stage biotech startup developing novel tumor-targeting therapeutics for solid tumors.
Don't miss TwoStep Therapeutics's next move
Get an email the moment TwoStep Therapeutics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Predictive Intelligence
Strategic
ML-powered predictions for TwoStep Therapeutics's next move
Palo AltoBiotechnology